Matthew L. Kaplan
Director, Nuvectis Pharma, Inc.
Companies
- Nuvectis Pharma, Inc.Board member Feb 8, 2022 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Nuvectis Pharma, Inc. NVCT159,760 shares2$3.0M at $18.67Jun 11, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 11, 2026Granted 35,000 shares of Nuvectis Pharma, Inc.2
- Nov 5, 2025Bought 11,000 shares at $5.84 of Nuvectis Pharma, Inc.3
- Jun 12, 2025Granted 30,000 shares of Nuvectis Pharma, Inc.4
- Jun 13, 2024Granted 30,000 shares of Nuvectis Pharma, Inc.5
- Jun 16, 2023Granted 18,000 shares of Nuvectis Pharma, Inc.6
- May 12, 2022Bought 1,823 shares at $17.47 of Nuvectis Pharma, Inc.7
- May 12, 2022Bought 1,177 shares at $15.96 of Nuvectis Pharma, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNuvectis Pharma, Inc., Board member
- 2
- 3SEC EDGARForm 4 filed Nov 6, 2025
- 4SEC EDGARForm 4 filed Jun 12, 2025
- 5SEC EDGARForm 4 filed Jun 13, 2024
- 6SEC EDGARForm 4 filed Jun 20, 2023
- 7SEC EDGARForm 4 filed May 16, 2022